Reduced nitric oxide production is associated with pathological changes in the cardiovascular system. In a study of randomly chosen families, we analysed the relationship between two polymorphisms (Glu298Asp and intron 4) of the endothelial nitric oxide synthase (eNOS) and ambulatory blood pressure (ABP), left ventricular mass index (LVMI) and vascular phenotypes. The study population consisted of 127 parents and 167 offspring. All subjects underwent 24 h ABP monitoring using a SpaceLabs 90207 device. 2D and M-mode echocardiograms were obtained. Pulse wave velocity between the common carotid and femoral artery was measured with the Complior s device, and the carotid intima-media thickness (IMT) was assessed by ultrasound. For statistical analysis, covariables and correlations between relatives were taken into account. The frequency of genotypes was as follows: for Glu298Asp:
Introduction
Nitric oxide (NO) in endothelial cells is synthesized from L-arginine by a catalyst enzyme-endothelial nitric oxide synthase (eNOS). A constitutive isoform of eNOS gene is expressed in vascular endothelium. 1 Mice lacking eNOS gene have higher blood pressure, insulin resistance, hyperlipidaemia 2 and advanced atherosclerosis. 3 The significant role of NO in the regulation of basal and inducible vasorelaxation suggests that abnormal eNOS activity caused by eNOS mutation may be associated with a number of pathologies such as arterial hypertension or atherosclerosis. 4 Furthermore, it has been shown that NO release and synthesis are decreased in patients with atherosclerosis. 5 The endothelium-derived NO is significantly involved in the regulation of vascular wall tone. 6 Disruption of the gene encoding eNOS in mice results in the development of arterial hypertension, 7 and humans with hypertension have been found to have impaired NO synthesis. 8, 9 Experimental inhibition of NO synthesis accelerates formation of early plaque. 10 Genetic variability is a highly probable factor predisposing to the development and progression of atherosclerosis. Functional polymorphisms in the gene encoding eNOS may modulate early stages of this disease.
A number of polymorphisms in the eNOS gene have been identified so far. Point mutation in exon 7 of the eNOS gene, resulting in a guanine-thymine substitution (G-T) at position 1917 and leading to a substitution of glutamic acid for aspartic acid (Glu298Asp), seems to affect the function of eNOS protein. 11 Furthermore, a 27-base-pair (27-bp) repeat polymorphism in intron 4 has been identified. A larger 4b allele contains five repeats of the 27-bp fragment, whereas the smaller one contains only four and is associated with a lower level of NO metabolites. 12, 13 As NO seems to have multiple atheroprotective effects, we hypothesized that the eNOS Glu298Asp polymorphism may be a risk factor for susceptibility to cardiovascular alterations. In the present study of families, selected at random in the general population, we analysed the relationship between polymorphisms of the eNOS gene (in exon 7 and intron 4) and ambulatory blood pressure (ABP), left ventricular mass (LVM), intimamedia thickness (IMT) and pulse wave velocity (PWV).
Methods

Epidemiological methods
The study population was recruited in the European Project on Genes in Hypertension (EPOGH). 14 The epidemiological methods used in the EPOGH study were previously described in detail. 15 In addition to the standardized EPOGH protocol, the Polish participants underwent echocardiography, vascular measurements and genotyping for eNOS gene polymorphisms. The study was conducted in accordance with the Declaration of Helsinki recommendations, 16 and it was approved by the Bioethics Committee at Jagiellonian University Medical College in Krakó w. All participants gave their written consent to the study.
Nuclear (two-generation) families, consisting of at least one parent and at least two siblings, all family members ranging in age from 18 to 60 years, were recruited from the general population. Based on the voting lists, the index persons were randomly selected and enquiries were made about their family structure and willingness to participate in the study. Of the 158 nuclear families fulfilling the inclusion criteria, members of 54.5% (n ¼ 86) families agreed to participate in the study. The index persons who did not agree to participate in the study were slightly older than those who were willing to participate (mean age 38.575.2 vs 34.274.8 years, Po0.05). Epidemiological data were obtained from 326 subjects. Those (1) who did not agree to undergo echocardiographic and vascular examinations (n ¼ 27), (2) in whom the quality of echocardiograms was insufficient (n ¼ 2) and (3) who had left ventricular dysfunction after myocardial infarction (n ¼ 2) or valvular heart disease (n ¼ 1) were excluded from further analysis, and finally 294 subjects were available for analysis.
Conventional blood pressure was measured five times consecutively at each of the two separate home visits. Casual blood pressure was taken as a mean of five consecutive measurements at the second home visit. Arterial hypertension was diagnosed if the mean of five measurements was X140 mmHg for systolic and/or 90 mmHg for diastolic blood pressure, or when the participant was taking antihypertensive agents.
Oscillometric blood pressure monitors (SpaceLabs 90207, Redmond, WA, USA) were programmed to measure blood pressure every 15 min between, 08:00 and 22:00, and every 30 min between 22:00 and 08:00. In accordance with the most recent recommendations, 17 the waking period was from 10:00 to 20:00, and the sleeping period from 24:00 to 06:00.
A standardized questionnaire was administered to obtain personal medical history, family history, data on certain beverages, physical activity and chronic consumption of drugs.
Echocardiographic and vascular measurements
Echocardiograms were performed using a HewlettPackard Sonos 2000 with a 3.5 MHz transducer. Mmode echocardiographic measurements of the left ventricle were obtained in the parasternal long axis guided by 2D echocardiography, with a crosssectional axis below the mitral valve at the level of the posterior tendinous chord. According to the recommendations of the American Society of Echocardiography, the following measurements were performed: left ventricular internal dimension (LVID), interventricular septal (IVS) and posterior wall thickness (PWT). 18, 19 An average of measurements obtained during three consecutive cardiac cycles was taken for statistical analysis. Left ventricular end-diastolic dimensions were used to calculate LVM 19 according to an anatomically defined formula. 20 Left ventricular mass index (LVMI) was obtained by dividing LVM by body surface area. 20 Carotid artery examinations were performed with a Hewlett-Packard Sonos 2000 scanner equipped with a 7.5 MHz transducer. The IMT was measured on both body sides, on the proximal and distal common carotid artery wall about 2.0 cm from the bifurcation. 21 The same observer (AO) provided all echocardiographic as well as carotid IMT measurements. The intraobserver intrasession reproducibility coefficient was 2.5% for LVM and 3.2% for carotid IMT.
PWV was measured with a Complior s device (Complior, Colson, Garges les Genosse). The TY-36-Fukuda pressure transducers were placed over the common carotid artery and the femoral artery on the eNOS and vascular remodelling D Czarnecka et al right side. PWV was calculated by dividing the distance between the transducers by the distance between the peaks of carotid and femoral pulse waves.
The result was averaged from 20 measurements.
Genetic measurements
Genome DNA was extracted from peripheral blood leucocytes using the Qiagen DNA kit. Genotypes were determined by polymerase chain reaction (PCR) using PCR kit Qiagen and Tag polymerase Qiagen Company. The VNRT polymorphisms in intron 4 of the eNOS gene were determined according to Wang et al, 22 using the 27-bp primers: sense 5 0 -GGC CCT ATG GTA GTG CCT TT-3 0 and antisense 5 0 -TCT CTT AGT GCT GTG GTC AC-3 0 (DNA-Gdansk Company). The PCR products were separated on 3% agarose gel. 22 The lengths of the separated fragments were 441 bp (five repeats-4b) and 414 bp (four repeats-4a) allowing the identification of three genotypes: b/b, b/a, a/a. The Glu298Asp polymorphism of eNOS gene was determined by the polymerase chain reaction-restriction fragment length polymorphism (RFLP-PCR). The specific sense and antisense primers 5 0 -AAG GCA GGA GAC AGT GGA TGGA-3 0 and 5 0 -CCC AGT CAA TCC CTT TGG TGC TCA-3 0 (DNA-Gdansk Company) were used in the PCR reaction. The PCR products were digested with restriction enzyme BanII (GibcoBRL); the mutant allele (T) has no BanII cutting side. The digestion products were separated on a 2% agarose gel and visualized by ethidium bromide staining. 23 
Statistical analysis
The SAS, version 8.2 software (SAS Institute Inc., Cary, NC, USA), was used to create database and perform most statistical analyses. A traditional test of association and family-based analysis were performed in the study group. Association analysis was based on the GEE method (generalized estimating equations) allowing for consideration of covariables and within-family relationships. 24 Quantitative transmission disequilibrium tests (QTDT) were performed in family-based analysis using three methods: an orthogonal model proposed by Abecasis et al 25, 26 in the QTDT software, version 2.3 (http://www.sph.umich.edu/csg/abecasis/QTDT), Allison model 27 and a logistic regression model.
28
Results
The study population (n ¼ 294) consisted of 127 parents and 167 offspring. Subject characteristics are summarized in Arterial hypertension diagnosed from conventional blood pressure measurements was significantly more frequent in parents than in offspring (55.9 vs 13.2%, P ¼ 0.001). Among parents, 38 subjects (29.9%) were regular cigarette smokers at the time of the study, and 25 subjects (24.6%) admitted alcohol consumption equal to or exceeding 5 g of pure ethanol daily. Among offspring, the numbers corresponded, respectively, to 41 (24.6%) and 33 subjects (19.8%). Differences between sexes showed a similar tendency in both groups and are summarized in Table 1 .
The frequencies of Glu298Asp (P ¼ 0.68) and intron 4 (P ¼ 0.29) polymorphisms of the eNOS gene were in Hardy-Weinberg equilibrium. The frequencies of genotypes and alleles did not differ between hypertensives and normotensives ( Table 2 ).
The following variables were considered in statistical analysis of blood pressure: age, sex, body mass index, antihypertensive treatment, smoking and regular alcohol intake. Analysis of LVM and IMT included age, sex, conventional systolic blood pressure, antihypertensive treatment and the above-mentioned lifestyle factors. Analysis of PWV additionally included heart rate at the time of the study. Analysis of offspring additionally included within-family relationships between phenotypes and genotypes.
There was no relationship between the Glu298Asp polymorphisms of eNOS gene and ABP either in parents or their offspring (Tables 3 and 4) . Similarly, LVMI did not differ between genotypes of Glu298Asp polymorphisms in both study groups. Among parents, carriers of the 298Asp allele had higher IMT values as compared with Glu/Glu homozygotes (0.94 vs 0.70 mm; P ¼ 0.007; Table 3 ). Among offspring, there was a similar tendency (0.60 vs 0.53 mm; P ¼ 0.10; Table 4 ). Neither in parents nor in offspring did we observe any association between the Glu298Asp polymorphism of eNOS and PWV. The 27-bp repeat polymorphism in intron 4 was not associated with the study phenotypes either (Tables 3 and 4 ).
An orthogonal model proposed by Abecasis did not show stratification of the study population for any phenotype (PX0.45). Among offspring, the three QTDT models revealed a tendency towards the relationship between the Glu298Asp polymorphism of eNOS gene and carotid IMT (Table 5 ). There was no relationship between the investigated eNOS gene polymorphisms in intron 4 and the study phenotypes (Table 5) .
Discussion
The present study was undertaken to assess phenotypes of the Glu298Asp and intron 4 polymorphisms of eNOS gene. The leading finding among parents eNOS and vascular remodelling D Czarnecka et al was more advanced carotid artery remodelling measured from the IMT in carriers of the 298Asp allele. A similar tendency, later confirmed by family structure analysis, was observed in offspring. There was no relationship between the polymorphisms and ABP, LVMI or PWV.
Atherosclerosis is the leading cause of mortality in industrialized countries. 29 Dysfunction and morphological endothelial changes appear to be critical for the occurrence and progression of clinical manifestation of atherosclerosis. 30 NO is one of the most important endothelium-derived substances that affects importantly the function and morphology of the vascular wall. For this reason, eNOS gene is a target gene for atherosclerosis. Computer-aided analysis of eNOS protein revealed that mutation of the Glu298Asp modifies the particle conformation, 31 suggesting that the presence of the 298Asp allele Carotid IMT is related to the frequency of cardiovascular diseases and is a risk factor for cardiovascular events. 35, 36 The higher risk for the development of symptoms of vascular remodelling and early atherosclerosis in carriers of the 298Asp allele of eNOS gene in the present study may suggest that the associated altered eNOS protein structure aggravates atherosclerotic mechanisms. Increased IMT might be also associated with older age, male gender or higher systolic blood pressure. In our study, however, the Glu298Asp genotypes were not different with regard to age, gender distribution or Results are given as means (s.e.) adjusted for sex, age, antihypertensive medication, smoking and regular alcohol consumption. Additionally, blood pressure phenotypes are adjusted for body mass index, left ventricular mass index and vascular phenotypes for systolic blood pressure and pulse wave velocity for heart rate. Results are given as means (s.e.) adjusted for sex, age, antihypertensive medication, smoking and regular alcohol consumption. Additionally, blood pressure phenotypes are adjusted for body mass index, left ventricular mass index and vascular phenotypes for systolic blood pressure and pulse wave velocity for heart rate.
eNOS and vascular remodelling D Czarnecka et al blood pressure level. We may only speculate that increased carotid IMT in carriers of the 298Asp allele of eNOS gene reflects their susceptibility to overreaction with vascular remodelling even to blood pressure values similar to 298Glu homozygotes. The Glu298Asp polymorphism of eNOS and its contribution to atherosclerosis has been extensively studied, yielding controversial results in various populations. As in our study, Lembo et al 37 found in a group of patients screened for hypertension an excess of Asp/Asp homozygotes among subjects who had atherosclerotic plaques on their carotid arteries compared with subjects without carotid plaques. Conversely, the SAPHIR study and observations in the Finnish population did not reveal the effect of the Glu298Asp polymorphism on the carotid arterial IMT. 38, 39 Similarly Markus et al 40 found that this particular polymorphism was not associated with the presence of transient cerebral attacks (TIA), stroke or carotid arterial stenosis in the British population. Our findings are also in concordance with the observations in eNOS knockout mice, which have been found to have increased IMT. 41 In the present study, polymorphism in intron 4 of eNOS gene was not associated with carotid IMT. Conversely, Japanese investigators in haemodialysed patients found the odds ratio for carotid plaque was increased to 3.72 by the 4a allele of the intron 4 polymorphism. 42 In the present study, among offspring, we have not observed any association between the Glu298Asp polymorphism and PWV. Similarly, other investigators did not find the relationship between this particular polymorphism and arterial stiffness. 43 ABP as a continuous variable was not associated with Glu298Asp or intron 4 polymorphisms of eNOS in the present study. There were no differences in the frequency of genotypes and alleles between hypertensives and normotensives. Several studies have been undertaken to determine the relationship between eNOS gene and arterial hypertension, demonstrating an association between the Glu298Asp polymorphism of eNOS and hypertension. However, studies in various ethnic populations produced conflicting results. In the French population, the 298Glu allele was more common in hypertensives as compared with the controls, 43 whereas the population-based Suita Study in Japan involving 4055 subjects did not find differences in blood pressure with respect to the Glu298Asp polymorphism. 44 There are also negative findings in the white Caucasian populations. 45, 46 As regards the 4a allele of the eNOS gene, Pulkkinen et al 47 demonstrated an association with elevated blood pressure. The association of this particular allele with elevated blood pressure was also found in the Japanese population. 48, 49 Conversely, Anglo-Celtic Australians did not show the association between the 4a allele of eNOS and arterial hypertension. 46 In the present study, there was no relationship between any of the polymorphisms of eNOS and LVM. In accord with our findings, Karvonen et al 45 did not find the association between the Glu298Asp polymorphism of eNOS and LVM in the Finnish population. The association between the Glu298Asp polymorphism and LVM has been found only in the Japanese population. 50 The present findings should be interpreted after consideration of possible study limitations. The data obtained in our study might only be generalized for the subjects with age ranging from 18 to 60 years. The discrepancies between our findings and those of other groups might depend on several factors, including selection of subjects. Although our study is population-based, we only recruited members of two-generation families, whereas other studies had either the case-control 37, 38, 40 or population-based cross-sectional 39 design. However, in our study, the two-generation groups had increased IMT in the carotid artery in carriers of the 298Asp allele of eNOS, confirmed by QTDT tests ( Table 6 ). The current findings suggest that screening for the 298Asp allele of the eNOS gene might detect subjects specially prone to vascular remodelling and early development of atherosclerosis. In conclusion, our study shows that the Glu298Asp polymorphism of the eNOS gene identifies patients with increased carotid arterial IMT, even in younger age groups. However, there is no relationship between this particular polymorphism, LVM or PWV. The 27-bp repeat polymorphism in intron 4 of eNOS was not related to cardiovascular phenotypes in our population. 
